Romana Suša

Dr. Romana Suša

Clinic for Pulmonology , University Clinical Center Kragujevac

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Medicina
Verified
Journal Article
Open access
PDF file
RSRomana Suša
Romana Suša
MRMiloš Ratinac
Miloš Ratinac
VCVojislav Cupurdija
Vojislav Cupurdija
LNLjiljana Novković
Ljiljana Novković
MMMirjana Milojević-Ilić
Mirjana Milojević-Ilić
ICIvan Cekerevac
Ivan Cekerevac
Background and Objectives: The Baveno classification represents a new approach to the assessment of the severity of OSA (Obstructive sleep apnea), which takes significant comorbidities into account: atrial fibrillation, arterial hypertension, heart failure, stroke, diabetes mellitus, and OSA symptoms expressed through the Epworth sleepiness scale (ESS). The authors believe that the Baveno classification facilitates a better stratification of patients with OSA and can be a good guide for deciding on the therapeutic approach and clinical monitoring of patients with OSA, compared to the AHI (apnea-hypopnea index) itself. The aim of this paper is to confirm the advantage of applying the Baveno classification to the evaluation of symptoms of anxiety and depression in the OSA patients compared to the application of the AHI as a single parameter. Materials and Methods: This research represents an observational retrospective study that was performed at the Pulmonology Clinic of the University Clinical Center in Kragujevac, Serbia. The study sample included 104 patients with diagnosed OSA. Patients were divided into four categories retrogradely according to the Baveno classification (A, B, C, and D). Statistical data processing was performed using the IBM SPSS Statistics version 25.0 program. Results: In our study, we proved that the Baveno classification is better at predicting the depressive disorder in OSA patients compared to the AHI itself, according to abnormal BDI-II (Beck Depression Inventory) score (value greater than ten) and HADS-D (Hospital anxiety and depression) scale (value greater than eight). The average AHI in the entire group of examined patients was 44.3 ± 19.8, while in category A the average AHI was 25.2 ± 10, in category B, 53.4 ± 20.6; in category C, 38.2 ± 18.5; and in category D, 48.1 ± 19.2. In the total sample, AHI did not correlate with the depressive episodes, but individually, the highest frequency of the depressive symptoms was precisely in the categories with the highest AHI (group D and B), where more than half of the subjects had an abnormal score. The frequency of the anxiety disorder (HADS-A) between the analyzed groups did not differ significantly, although the largest number of patients with significant anxiety were in category B, according to the Baveno classification. Conclusions: We proved that the Baveno classification is applicable in real life, and it is better at evaluating anxiety and depression using questionnaires and can identify new patients who need CPAP therapy, independently of other OSAS symptoms, primarily daytime sleepiness.

1 January 2017 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
ICIvan Cekerevac
Ivan Cekerevac
ZLZorica Lazic
Zorica Lazic
LNLjiljana Novkovic
Ljiljana Novkovic
MPMarina Petrovic
Marina Petrovic
VCVojislav Cupurdija
Vojislav Cupurdija
RSRomana Suša
Romana Suša
Introduction/Objective. The origin of depressive disorder in chronic obstructive pulmonary disease (COPD) patients is still not completely known and probably is caused by various factors. The aim of this study is to establish the most important characteristics of COPD patients who have depressive disorder. Methods. Eighty-nine COPD patients and 65 demographically-matched referents without COPD were included. All the patients underwent lung function examination, and gas exchange, nutritional status, dyspnoea level by the modified Medical Research Council (mMRC) scale and exercise tolerance were also assessed, as well as depressive disorder by Hospital Anxiety and Depression Scale (HADS) and Geriatrics Depression Scale (GDS) and quality of life by St. George?s Respiratory Questionnaire (SGRQ). Results. Depressive disorder has been found in 30.3% of COPD patients evaluated by HADS and 25.3% of COPD patients evaluated by GDS. When COPD subjects were stratified by forced expiratory volume in 1 second (FEV1) categorization, all subgroups were more likely to have depressive disorder, according to HADS and GDS, relative to referents with the odds ratio highest (3: 95% confidence interval 1.6?4.9) among those with the FEV1 < 30%. COPD patients with depressive disorder (HADS) compared to non-depressed patients had (differences in mean values) higher intensity of smoking [6.9 (0.5?10.1)], lower body mass index [-4.9 (-7.2?5.4)], lower value of FEV1% [-8.3 (-16.3?1.2)] , higher value of total lung capacity (%) [17.8 (2.3?28.4)], higher mMRC score (1.07 (-1?3.0), and higher SGRQ ? giving a total score of 32.9 (24.1?40.3). Conclusion. Evaluation of depressive disorder should be considered in every patient with COPD, especially in patients with greater degree of airflow limitation and lung hyperinflation, dyspnoea level and malnourished.

29 September 2021 in International Heart Journal
Verified
Journal Article
Open access
PDF file
DDDanijela Djokovic
Danijela Djokovic
MMMaja Dragan Murić
Maja Dragan Murić
NMNemanja Muric
Nemanja Muric
INIvana P Nedeljkovic
Ivana P Nedeljkovic
Stefan SimovicStefan Simovic
Stefan Simovic
ICIvan Cekerevac
Ivan Cekerevac
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.

22 March 2021 in Medicina
Verified
Journal Article
Open access
PDF file
RSRomana Suša
Romana Suša
VCVojislav Cupurdija
Vojislav Cupurdija
LNLjiljana Novković
Ljiljana Novković
MRMiloš Ratinac
Miloš Ratinac
SJSlobodan Janković
Slobodan Janković
ICIvan Cekerevac
Ivan Cekerevac
Background and Objectives: This paper aims to show whether obstructive sleep apnea (OSA) severity increases the level of systemic inflammation markers regardless of body mass index (BMI) and body composition. Materials and Methods: In total, 128 patients with OSA were included in the study. Examinees were divided into two groups: one with mild OSA (apnea–hypopnea index (AHI) < 15) and one with moderate and severe OSA (AHI ≥ 15). Nutritional status was assessed using body mass index, body composition by dual X-ray absorptiometry. Systemic inflammation was assessed on the basis of plasma concentrations of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and serum level of C-reactive protein (CRP). Results: We found elevated mean values of the evaluated systemic inflammation markers (CRP, TNF-α, IL-6) in a group with AHI ≥ 15, although there was no statistical significance. Our research found a significant positive correlation with BMI (r = 0.633, p < 0.001), as well as with body fat percentage (r = 0.450, p = 0.024) and serum CRP values. Significant correlation was found between the plasma IL-6 concentration and body fat percentage (FM%) (r = 0.579, p = 0.003) and lean body mass (r = −0.501, p = 0.013). Multivariate regression analysis did not show any independent predictor (parameters of OSA, nutritional status, body composition) of the systemic inflammation markers. Conclusions: Neither one tested parameter (nutritional status and body composition) of the severity of OSA was identified as an independent prognostic factor for the severity of systemic inflammation in patients with OSA.

1 January 2016 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
VCVojislav Cupurdija
Vojislav Cupurdija
ICIvan Cekerevac
Ivan Cekerevac
MPMarina Petrovic
Marina Petrovic
GKGordana Kostic
Gordana Kostic
RSRomana Suša
Romana Suša
ZLZorica Lazic
Zorica Lazic

1 January 2025 in Medicinski casopis
Verified
Journal Article
Open access
PDF file
DADejan Aleksic
Dejan Aleksic
SLSnezana Lazarević
Snezana Lazarević
RSRomana Suša
Romana Suša
ZLZorica Lazic
Zorica Lazic
ICIvan Cekerevac
Ivan Cekerevac
GTGordana Tončev
Gordana Tončev
Objective. Recent research suggests that neuroinflammation may play a crucial role in age-related cognitive dysfunction. Studies have investigated the impact of leukotriene receptor (LTR) antagonist montelukast, a medication commonly used to treat allergies and asthma, on the risk of developing dementia. The aim of this study was to compare cognitive functions in asthmatic patients who used montelukast, those who did not use it, and healthy controls. Methods. In this study 50 asthmatic patients (age 67.34±6.44; 20 montelukast users and 30 non-users) were matched with 50 healthy controls (age 68.08±5.95). Each participant was assessed using the Mini Mental State Examination (MMSE) and the Montreal Cognitive Test (MoCA). Memory coefficients (verbal, visual, general, delayed memory, and attention and concentration) were measured by Wechsler Memory Scale-Revised (WMS-R). Results. Orientation, as MoCA subdomain, was worse in patients with asthma compared to the control group (p=0.048). Asthmatic patients treated with montelukast had a significantly higher MoCA score (p=0.033), dominantly due to delayed recall, (p=0.044) than patients without montelukast treatment. People with asthma on montelukast therapy showed statistically significantly better results on the MoCA test (p=0.037) compared to the control group (dominantly due to attention (p=0.032) and delayed recall (p=0.021)). A multiple linear logistic regression model showed statistical significance (p=0.025). The use of montelukast had significant impact on the results of the MOCA test (p=0.012). Conclusion. Montelukast group had better results on MoCA (dominantly due to delayed recall) compared to montelukast non-users. Studies with a larger number of participants are needed to confirm the effect of montelukast on the cognitive status of the elderly.